Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer. Clin Cancer Res. 2013 Dec 15; 19(24):6891-901.

View in: PubMed

subject areas

Biomarkers, Tumor
Bone Neoplasms
C-Reactive Protein
Disease-Free Survival
Humans
L-Lactate Dehydrogenase
Male
Neoplasm Metastasis
Prostatic Neoplasms, Castration-Resistant
Quinolines
Quinolones
Survival Analysis
Vascular Endothelial Growth Factor A

authors with profiles

Walter M. Stadler